Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease
Conditions: Non-Alcoholic Fatty Liver Disease Interventions: Drug: Empagliflozin 10 MG; Drug: Placebo Oral Tablet Sponsors: Ann& Robert H Lurie Children ' s Hospital of Chicago Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
A Study to Evaluate Safety and Feasibility of Robotic Liver Resection
Conditions: Liver Diseases; Surgery Interventions: Device: Robotic liver resection Sponsors: Zhejiang University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Digital Therapeutic Lifestyle Intervention Program for Patients With MASLD
Conditions: NASH; NASH - Nonalcoholic Steatohepatitis; Liver Diseases Interventions: Other: Noom Weight Application Sponsors: Milton S. Hershey Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2024 Category: Research Source Type: clinical trials
Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Adults MASLD Patients (DELI_MASLD Study)
Conditions: Metabolic Dysfunction Associated Steatotic Liver Disease; Steatotic Liver Disease; Hepatic Steatosis Interventions: Dietary Supplement: Probiotic lysate (postbiotic and metabiotc); Dietary Supplement: Placebo Sponsors: Bogomolets National Medical University; Taras Shevchenko National University of Kyiv; Danylo Halytsky Lviv National Medical University; Kyiv City Clinical Endocrinology Center; Center for Innovative Medical Technologies of the National Academy of Sciences of Ukraine; MirImmunoFarm; Stellar Biotics Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2024 Category: Research Source Type: clinical trials
Motivational Interviewing in the Management of Non Alcoholic Fatty Liver Disease
Conditions: Non-Alcoholic Fatty Liver Disease Interventions: Behavioral: Motivational Interview; Behavioral: Placebo Sponsors: Madunil Anuk Niriella Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials
AGED Diagnostics Liver Disease Assessment
Conditions: NASH With Fibrosis; NAFLD; Healthy Interventions: Diagnostic Test: AGED Multiple Target Assay in Healthy Controls; Diagnostic Test: AGED Multiple Target Assay in NAFLD Participants; Diagnostic Test: AGED Multiple Target Assay in Fibrosis Participants Sponsors: Active Genomes Expressed Diagnostics, Corp; Arizona Clinical Trials; Walter Reed National Military Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2024 Category: Research Source Type: clinical trials
Digital Pathology and AI for Liver Outcomes in MASLD
Conditions: Metabolic Dysfunction-associated Steatotic Liver Disease Interventions: Diagnostic Test: Digital Pathology FibroNest Phenotypic Fibrosis Composite Score (Ph-FCS) Sponsors: PharmaNest, Inc; Chinese University of Hong Kong; University of Edinburgh; University of Seville; Imperial College London; Icahn School of Medicine at Mount Sinai; Fundacio Clinic Barcelona Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials
First Patient Dosed in Phase 2a Clinical Trial of a First-in-Class Regenerative Cell Therapy for Patients with End-Stage Liver Disease
PITTSBURGH, April 2, 2024. LyGenesis, a clinical-stage biotechnology company developing cell therapies for large unmet medical needs, announced today that the first patient has been dosed in their Phase 2a clinical trial... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - April 2, 2024 Category: Pharmaceuticals Source Type: clinical trials
A Study to Learn How the Body Processes the Study Medicine Called Osivelotor (PF-07940367) in People With Loss of Liver Function
Conditions: Liver Diseases Interventions: Drug: Osivelotor Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
Safety and Efficacy of Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurement
Conditions: Liver Diseases Interventions: Procedure: Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurement Sponsors: Methodist Health System Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
Manual Therapy in Metabolic Liver Disease
Conditions: NAFLD, Non-alcoholic Fatty Liver Disease Interventions: Procedure: liver treatment protocol Sponsors: University of Seville Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
The Impact of Different Exercise Modes on Bile Acid Levels and Liver Function in Patients With Non-alcoholic Fatty Liver Disease
Conditions: Non-alcoholic Fatty Liver Disease NAFLD Interventions: Behavioral: Aerobic training (AT); Behavioral: Resistance training (RT); Behavioral: Combined aerobic and resistance training (AT + RT) Sponsors: Xuzhou Medical University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
A Research Study on Etavopivat in Participants With and Without Liver Disease
Conditions: Liver Diseases Interventions: Drug: Etavopivat Sponsors: Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials
Risk Factors and Impact MASLD in Patients With IBD
Conditions: Metabolic Dysfunction-associated Steatotic Liver Disease Interventions: Device: FibroScan Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
Clinical Characteristics of Metabolic Associated Fatty Liver Disease
Conditions: Metabolic Associated Fatty Liver Disease; Clinical Features Sponsors: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
